OTLKW
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
OTLKW
Delisted
OTLKW was delisted on the 16th of February, 2022.
6 hedge funds and large institutions have $200K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $72K | +$72K | +420,875 | New |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $64K | +$64K | +416,666 | New |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $27K | +$27K | +177,439 | New |
|
|
MWNA
4
Marshall Wace North America
New York
| $21K | +$21K | +125,400 | New |
|
|
PC
5
PointState Capital
New York
| $12K | +$12K | +100,000 | New |
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$4K | +24,311 | New |
|